Prevalence of function-limiting late effects in survivors of head and neck cancer

被引:0
|
作者
Won, Yu Hui [1 ,2 ]
Stubblefield, Michael D. [3 ,4 ,5 ,6 ]
机构
[1] Jeonbuk Natl Univ, Med Sch, Dept Phys Med & Rehabil, Jeonju, South Korea
[2] Jeonbuk Natl Univ, Jeonbuk Nat Univ Hosp, Res Inst Clin Med, BiomedicalRes Inst, Jeonju, South Korea
[3] Kessler Inst Rehabil, Canc Rehabil, West Orange, NJ USA
[4] Select Med, Complex Med Rehabil Inpatient Rehabil Hosp Div, Mechanicsburg, PA USA
[5] Select Med, ReVital Canc Rehabil, Mechanicsburg, PA USA
[6] Rutgers New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA
来源
关键词
CRANIAL NERVE PALSY; NASOPHARYNGEAL CARCINOMA; BAROREFLEX FAILURE; RADIOTHERAPY; DYSPHAGIA; COMPLICATIONS; LYMPHEDEMA; OUTCOMES;
D O I
10.1002/pmrj.13340
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Background: Survivors of head and neck cancer (HNC) are commonly affected by multiple complex and interrelated long-term and late effects that can adversely affect their function and quality of life. Objective: To define the prevalence of neuromuscular, musculoskeletal, visceral, oncologic, and other late effects affecting function and quality of life in survivors of HNC. Design: Retrospective cohort analysis. Setting: Outpatient cancer rehabilitation clinic at a physical medicine and rehabilitation hospital that includes a freestanding inpatient rehabilitation unit along with an outpatient clinic. Participants: One hundred thirty survivors of HNC who sought specialized cancer rehabilitation services to address complex functional impairments. Interventions: Not applicable. Main Outcome Measures: Prevalence of neuromuscular, musculoskeletal, visceral, oncologic, and other late effects affecting function and quality of life in survivors of HNC. Results: The majority underwent surgery (53.8%), chemotherapy (22.3%), and radiation therapy (93.8%) as part of their treatment. Neuromuscular complications such as myelopathy (45.4%), radiculoplexopathy (58.5%), mononeuropathy (84.6%), and myopathy (57.7%) were prevalent. Musculoskeletal impairments included dysphagia (92.3%), dysarthria (60.8%), trismus (40.8%), cervical dystonia (47.7%), and shoulder dysfunction (27.7%). Visceral disorders encompassed lymphedema (86.2%), hypothyroidism (26.2%), and baroreceptor failure (19.2%). Additionally, oncologic complications, including recurrence (18.5%), metastasis (5.4%), and secondary malignancies (8.5%) were observed. Pain (74.6%) and fatigue (31.5%) were reported as major function-limiting impairments. Most survivors (96.9%) were referred to therapy including physical therapy (85.4%), occupational therapy (13.1%), speech-language pathology (84.6%), and lymphedema therapy (72.3%). Most (85.4%) required two or more therapy disciplines. Conclusion: Survivors of HNC accessing cancer rehabilitation services commonly present with diverse, complex, and interrelated neuromuscular, musculoskeletal, visceral, and oncologic late effects that can severely affect function and quality of life. Comprehensive rehabilitation should include evaluation and management of these complex and interrelated late effects by a rehabilitation team that includes cancer rehabilitation physicians, physical therapists, occupational therapists, lymphedema therapists, and speech-language pathologists, among others.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Documentation and incidence of late effects and screening recommendations for adolescent and young adult head and neck cancer survivors treated with radiotherapy
    Sarah Nicole Hamilton
    Omair Arshad
    Jaime Kwok
    Eric Tran
    A. Fuchsia Howard
    Isabel Serrano
    Karen Goddard
    Supportive Care in Cancer, 2019, 27 : 2609 - 2616
  • [42] Pain Prevalence in Head and Neck Cancer
    Van Cleave, Janet
    Brooks, Christopher
    Zahriah, Elise
    Riccobene, Ann
    Most, Allison
    Liang, Eva
    Concert, Catherine
    JOURNAL OF PAIN, 2022, 23 (05): : 29 - 29
  • [43] Comparison of the Financial Burden of Survivors of Head and Neck Cancer With Other Cancer Survivors
    Massa, Sean T.
    Osazuwa-Peters, Nosayaba
    Boakye, Eric Adjei
    Walker, Ronald J.
    Ward, Gregory M.
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2019, 145 (03) : 239 - 249
  • [44] Deterioration in quality-of-life of late (10-year) survivors of head and neck cancer
    Mehanna, HM
    Morton, RP
    CLINICAL OTOLARYNGOLOGY, 2006, 31 (03): : 204 - 211
  • [45] Prospective monitoring for radiotherapy late effects in head and neck cancer patients
    Clarke, Hazel
    Clifford, Laura
    Cook, Carol
    De Winton, Emma
    Lewis, Pippa
    MacKay, Fiona
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S5635 - S5637
  • [46] NTCP Modeling of Late Effects for Head and Neck Cancer: A Systematic Review
    Stieb, Sonja
    Lee, Anna
    van Dijk, Lisanne, V
    Frank, Steven
    Fuller, Clifton David
    Blanchard, Pierre
    INTERNATIONAL JOURNAL OF PARTICLE THERAPY, 2021, 8 (01) : 95 - 107
  • [47] LATE EFFECTS OF HYPERFRACTIONATED RADIOTHERAPY FOR HEAD AND NECK-CANCER - REPLY
    FU, KK
    COX, JD
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 32 (04): : 1266 - 1266
  • [48] Prevalence and risk factors associated with chronic pain among survivors of head and neck cancer.
    Jiang, Rong
    Chen, Meng
    White, Melissa Christina
    Ramos, Katherine
    Corbett, Cheyenne
    Watts, Tammara L.
    Graboyes, Evan Michael
    Osazuwa-Peters, Nosayaba
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [49] Prevalence and correlates of high-dose opioid use among survivors of head and neck cancer
    Nugent, Shannon M.
    Slatore, Christopher G.
    Winchell, Kara
    Handley, Robert
    Clayburgh, Daniel
    Chandra, Ravi
    Hooker, Elizabeth R.
    Knight, Sara J.
    Morasco, Benjamin J.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2023, 45 (08): : 2058 - 2067
  • [50] The effects of thymostimulin on immunological function in patients with head and neck cancer
    Kerrebijn, JDF
    Simons, PJ
    Tas, M
    Knegt, PP
    vandeBrekel, MWM
    Delaere, P
    Tan, IB
    Drexhage, HA
    Balm, AJM
    CLINICAL OTOLARYNGOLOGY, 1996, 21 (05): : 455 - 462